The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Clinical Validation of a Microfluidic Device for Isolation and Molecular Characterization of Circulating Tumor Cells
Official Title: Clinical Validation of a Microfluidic Device for Isolation and Molecular Characterization of Circulating Tumor Cells
Study ID: NCT01022723
Brief Summary: To evaluate the efficiency of a microdevice for circulating tumor cells isolation and to correlate the circulating titre with response and progression.
Detailed Description: * Validate the clinical use of a mircofluidic device to capture circulating timor cells from a broad range of tumor types * Characterize and identify these circulating tumor cells and demostrate cell viability with this capture method * Apply this technology in clinically relevant settings and correlate to response to treatment and disease progression * Elucidate predictive and pharmacodynamic biomarkers in the context of early phase trials of novel therapeutics
Minimum Age:
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
National Cancer Centre, Singapore, , Singapore
Name: Wan-Teck Lim, MD
Affiliation: National Cancer Centre, Singapore
Role: PRINCIPAL_INVESTIGATOR